Speech-Language Pathologists in Almo, KY Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Jessie Crider, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 193 Wells Purdom Dr, Almo, KY 42020 Phone: 270-293-3945 |
Mrs. Jennifer Renee' Severns, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 263 Lexie Ln, Almo, KY 42020 Phone: 270-293-7231 |
News Archive
Angelman Syndrome Foundation increases grant award for 2009 for AS research
The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than $988,000 in grants was awarded to six principle investigators, focusing on Angelman Syndrome (AS) research.
Study reveals underrepresentation of older people in COVID-19 trials
A study published today in the Journal of the American Medical Association Internal Medicine revealed that older persons are highly likely to be excluded from the majority of COVID-19 trials that seek to establish effective treatments, as well as find a preventive vaccine.
Ireland's Health Research Board awards €1.2M to UL researchers
University of Limerick researchers have been awarded over €1.2 million funding by Ireland's Health Research Board. The funding will support health research focused on; primary care reform in Ireland; avoidance of adverse outcomes in vascular surgery; dealing with the progression of chronic kidney disease and enhancing physical activity for multiple sclerosis patients.
Research provides important insights into genetic adaptation of SARS-CoV-2 to humans
In their groundbreaking paper available on the preprint server medRxiv, University of Pittsburgh researchers were appraising signals of SARS-CoV-2 genome evolution and found that purifying selection (i.e., removal of deleterious mutations) represents the dominant trait during early coronavirus disease (COVID-19) pandemic - suggesting that the virus will evolve as it diversifies in a growing number of hosts.
Drug helps children with attention deficit/hyperactivity disorder (ADHD)
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
› Verified 1 days ago